← Back to headlines
Zenas BioPharma Supported by Encouraging Phase II Trial Data
Zenas BioPharma (ZBIO) saw support in Q4 due to encouraging data from its Phase II trial.
19 Feb, 12:09 — 19 Feb, 12:09
Zenas BioPharma (ZBIO) saw support in Q4 due to encouraging data from its Phase II trial.
19 Feb, 12:09 — 19 Feb, 12:09
